학술논문

A detailed analysis of expedited regulatory review time of marketing authorization applications for new anticancer drugs in the US and EU
Document Type
Article
Source
In: Clinical and Translational Science. (Clinical and Translational Science, August 2022, 15(8):1959-1967)
Subject
Language
English
ISSN
17528062
17528054